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Abstract
Coronavirus host and cell specificities are determined by specific interactions between the viral spike (S) protein and host
cell receptor(s). Avian coronavirus infectious bronchitis (IBV) has been adapted to embryonated chicken eggs, primary
chicken kidney (CK) cells, monkey kidney cell line Vero, and other human and animal cells. Here we report that acquisition of
the cell–cell fusion activity by amino acid mutations in the S protein determines the infectivity of IBV in cultured cells.
Expression of S protein derived from Vero- and CK-adapted strains showed efficient induction of membrane fusion.
However, expression of S protein cloned from the third passage of IBV in chicken embryo (EP3) did not show apparent
syncytia formation. By construction of chimeric S constructs and site-directed mutagenesis, a point mutation (L857-F) at
amino acid position 857 in the heptad repeat 1 region of S protein was shown to be responsible for its acquisition of the
cell–cell fusion activity. Furthermore, a G405-D point mutation in the S1 domain, which was acquired during further
propagation of Vero-adapted IBV in Vero cells, could enhance the cell–cell fusion activity of the protein. Re-introduction of
L857 back to the S gene of Vero-adapted IBV allowed recovery of variants that contain the introduced L857. However,
compensatory mutations in S1 and some distant regions of S2 were required for restoration of the cell–cell fusion activity of
S protein carrying L857 and for the infectivity of the recovered variants in cultured cells. This study demonstrates that
acquisition of the cell–cell fusion activity in S protein determines the selection and/or adaptation of a coronavirus from
chicken embryo to cultured cells of human and animal origins.
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Introduction
Interspecies adaptation, replication and transmission in cells are
essential steps for an animal virus to emerge successfully in a
human population. Virus-cell and cell–cell membrane fusion,
mediated by fusion proteins associated with viral envelope, is
crucial for the entry of enveloped viruses into cells and for rapid
spread of infection to the neighboring cells. This membrane fusion
process may, therefore, be a limiting point for efficient adaptation
and infection of an animal virus in cells from a different host
species. In this study, we report that acquisition of the cell–cell
fusion activity by point mutations in the spike (S) protein of avian
coronavirus infectious bronchitis virus (IBV) plays a critical role in
adaptation and/or selection of a variant that infects cultured cells.
Coronavirus is a large family of enveloped, positive-stranded
RNA viruses that cause respiratory and intestinal infections in
avian and mammalian species [1]. IBV, the prototype member of
coronavirus, causes highly contagious diseases in chicken and is a
constant threat to the poultry industry. Coronavirus was
traditionally considered to have narrow host specificities [2].
However, the outbreaks of severe acute respiratory syndrome
(SARS), a serious zoonotic transmission event caused by a novel
coronavirus, demonstrate that a certain coronvirus species may
exhibit wider host specificities and suggests the possibility of cross-
species transmission of animal coronaviruses to human [3,4].
Cross-species transmission was also observed in coronavirus
transmissible gastroenteritis virus (TGEV) and human coronavirus
OC43 [5–7]. These events highlight the importance of under-
standing the mechanisms of interspecies adaptation and transmis-
sion of coronavirus.
The Beaudette strain of IBV was previously adapted to
embryonated chicken eggs. This embryo-adapted IBV strain was
subsequently adapted to cultured cells originated from chicken and
monkey. For example, the virus was adapted by serial passages to
primary chicken kidney (CK) cells [8,9] and the African green
monkey kidney cell line Vero cell [8–13]. Furthermore, the Vero-
adapted IBV is able to infect cultured human and animal cell lines
[14,15].
In a previous report, a total of 49 amino acid substitutions was
found during adaptation of IBV from chicken embryo (EP3) to
Vero cells (p65) [10–12]. Among them, 26 amino acid substitu-
tions are in the S protein [10]. In this study, expression of S
protein cloned from IBV strains EP3, CK, passage 7 (p7) and p65
of Vero-adapted IBV showed induction of cell–cell fusion by
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syncytial cells was observed in cells expressing S(EP3). Construc-
tion of chimeric S constructs and site-directed mutagenesis studies
identified a leucine to phenylalanine substitution at the amino acid
position 857 in the heptad repeat 1 region (L857-F) that confers
the non-fusogenic S protein to fusogenic. Re-introduction of the
F857-L mutation back to the genome of Vero-adapted IBV (p65)
showed rescue of virus containing the F857-L mutation. However,
compensatory mutations occurred in the S1 region that could
rescue the cell–cell fusion activity of S constructs carrying the
F857-L mutation.
Materials and Methods
Cells and viruses
Cells were maintained in DMEM supplemented with 10%
newborn calf serum. The Vero-adapted IBV and recombinant
vaccinia/T7 virus was propagated and titrated on Vero cells.
Virus stocks were kept at 280uC until use.
Immunofluorescent staining
Cell monolayers grown on 4 well slide chambers were infected
with vaccinia/T7 virus for 1 hour followed by transfection of
indicated plasmids using the Effectene transfection kit (Qiagen). At
12 hours post-transfection, cells were washed with phosphate
buffered saline (PBS) supplemented with 10% normal goat serum,
fixed with 4% paraformaldehyde in PBS for 15 minutes, and
permeabilized with 0.2% Triton X-100. Immunofluorescent
staining was performed by incubation of cells with rabbit anti-
IBV S polyclonal antibodies and subsequently with FITC-
conjugated anti-rabbit IgG. Cells were examined by fluorescent
microscopy and digital images were collected.
Western blotting
Protein samples were prepared from cells harvested at 12 hours
post-transfection, separated by SDS-PAGE and transferred to
PVDF membranes. The membranes were incubated with rabbit
anti-IBV S polyclonal antibodies or mouse anti-b-tubulin
monoclonal antibody (Sigma Aldrich), and subsequently with
HRP-conjugated anti-rabbit or -mouse IgG (DAKO). Polypep-
tides were detected using the enhanced chemiluminescence (ECL)
detection reagents (Amersham).
Flow cytometry
Vero cells were transfected as described above, and harvested at
12 hours post transfection. Cells were washed once with PBS,
resuspended in blocking buffer containing 20% FBS and 1% BSA
in PBS, and incubated on ice for 30 minutes. Subsequently, cells
were incubated with 0.1% saponin in FACS washing buffer
containing 2.5% FBS and 0.05% sodium azide in PBS for 10
minutes at room temperature when required. Immunofluorescent
staining was carried out with 1:100 diluted rabbit anti-IBV S
polyclonal antibodies, and 1:20 diluted FITC-conjugated swine
anti-rabbit antibody (DAKO). After washing two times with the
FACS washing buffer, cells were fixed with 1% ice cold
paraformaldehyde and analyzed by flow cytometry.
RT-PCR and Sequencing
Viral RNA was extracted from the culture supernatants or
infected cells using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s instructions. RT-PCR was performed using the
Expand Reverse Transcription and High Fidelity PCR Kits
(Roche). The PCR products were cloned into PCRH-XL-TOPOH
vector (Invitrogen) and sequenced by automated sequencing.
Construction of full-length wild type and mutant IBV
cDNAs, in vitro transcription and electroporation
Construction of the full-length IBV cDNA clones from p65 of
Vero-adapted IBV was previously reported [16,17]. The F857-L
point mutation was introduced into the corresponding fragment
using QuickChange site-directed mutagenesis kit (Stratagene), and
subsequently ligated into the full-length cDNA clone.
The full-length transcripts were generated in vitro using the
mMessage mMachine T7 kit (Ambion) according to the
manufacturer’s instructions with certain modifications. Briefly,
30 ml of transcription reaction with a 1:1 ratio of GTP to cap
analog were sequentially incubated at 40.5uC for 25 minutes,
37.5uC for 50 minutes; 40.5uC for 25 minutes, and 37.5uC for 20
minutes. The transcripts were extracted with phenol/chloroform.
Vero cells were grown to 90% confluence, trypsinized, washed
twice with cold PBS, and resuspended in PBS. RNA transcripts
were added to 400 ml of Vero cell suspension in an electroporation
cuvette, and one electrical pulse at 450 V, 50 mF was given using a
Bio-Rad Gene Pulser II electroporator. The transfected Vero cells
were cultured overnight in 1% FBS-containing MEM in a 60 mm
dish or a six-well plate and further cultured in MEM without FBS.
Construction of plasmids
The S genes from different passages of the Vero-adapted IBV
strain and CK-adapted IBV were amplified and cloned into pKT0
vector [18]. Chimeric S constructs were made by overlapping
PCR [19]. Point mutations were introduced by site-directed
mutagenesis using the Quikchange
TM kit (Stratagene). All
constructs were confirmed by automated nucleotide sequencing.
Results
Cell-cell fusion activity of S proteins cloned from EP3 and
CK-adapted Beaudette strain of IBV
Acquisition of the cell–cell fusion activity is essential for selection
and adaptation of coronavirus IBV from chicken embryo to
cultured cells [10]. Sequence comparison of two S protein
constructs, S(EP3) and S(CK), cloned from EP3 and CK-adapted
IBV strains, respectively, showed amino acid substitutions at 31
positions (Fig. 1a). The cell–cell fusion activity of these two S
constructs was analyzed by transfection into Vero cells using the
vaccinia/T7 recombinant virus system. Western blot analysis
showed the presence of major forms of S protein, including the
180-kDa glycosylated (S*) and 130-kDa unglycosylated full-length
S (S) and the cleaved S1 and S2 species (S1/S2) in cells expressing
the two constructs (Fig. 2a, lanes 2 and 3). It was noted that the
expression level of S(CK) was higher than S(EP3) (Fig. 2a). As a
negative control, cells transfected with IBV N protein were
included, and the expressed N protein was detected by Western
blot with anti-N antibodies (Fig. 2a, lane 1). Immunofluorescent
staining of Vero cells expressing S(CK) clearly showed syncytia
formation at 12 hours post-transfection (Fig. 2b, panel S(CK)).
However, in Vero cells expressing S(EP3), no obvious syncytia was
observed (Fig. 2b, panel S(EP3)). In the negative control cells, no
fusion of the transfected cells was detected (Fig. 2b, panel N).
To investigate the possibility that intrinsic differences in cell
surface translocation of the two S constructs may affect their cell–
cell fusion activity, cell surface expression of the two proteins was
analysed by flow cytometry after immunofluorescent staining with
anti-S antiserum. As shown in Fig. 2c, 0.57% of nonpermeabilized
(panel A) and 2.13% of permeabilized (panel D) cells expressing
empty plasmid exhibited background staining. Under nonpermea-
bilizing conditions, 1.9% (2.47–0.57) cells expressing S(EP3) (panel
B) and 2.93% (3.5–0.57) cells expressing S(CK) showed positive
Cell Culture-Adapted IBV
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2.13) of cells expressing S(EP3) protein (panel E) and 18.31%
(20.44–2.13) of cells expressing S(CK) (panel F) showed positive
staining. These results confirm that the two S proteins could be
translocated to the cell surface with a similar efficiency.
Acquisition of the cell–cell fusion activity by mutation of
a conserved leucine residue to phenylalanine (L857-F) in
the heptad repeat 1 region of S protein
To map the amino acid mutation(s) responsible for acquisition
of the cell–cell fusion activity of S(CK), three chimeric constructs
were first made. Construct EP3-CK(1) was made by replacing the
C-terminal 412 amino acid region of S(EP3) with the correspond-
ing region from S(CK), EP3-CK(2) was made by replacing the C-
terminal 280 amino acid region of S(EP3) with the corresponding
region from S(CK), and CK-EP3 was made by replacing the N-
terminal 882 amino acid region of S(EP3) with the corresponding
region from S(CK) (Fig. 3a). Western blot analysis of cells
expressing these constructs detected the S1 and S2 species as well
as the glycosylated and unglycosylated forms of the full-length S
protein (Fig. 3b, lanes 3–5). Immunofluorescent staining showed
cell–cell fusion and syncytia formation in cells expressing both
EP3-CK(1) and CK-EP3 (Fig. 3c, panels EP3-CK(1) and CK-
EP3), but not EP3-CK(2) (Fig. 3c, panel EP3-CK(2)). The relative
cell–cell fusion activities of these S constructs were semi-
quantitatively defined by comparing the average size of syncytia
induced by different S constructs with the average size (considered
as 1) of cells expressing S(EP3), and are listed in the order from
high to low as follows: CK-EP3.CK=EP3-CK(1)&EP3=EP3-
CK(2) (.indicates the relative activity is within 1 fold higher, and
&indicates more than 1 fold higher). These results demonstrate
that the region between amino acids 750 and 882 may determine
the fusogenic difference between S(EP3) and S(CK).
Examination of this region showed two amino acid substitutions
from S(EP3) to S(CK), i.e. N826 to S and L857 to F (Fig. 1b). To
determine which amino acid substitution dictates the fusogenic
change, three mutant constructs were made. Constructs
CK3(S826-N) and CK(F857-L) were made by mutation of the
S826 and F857 residues in S(CK) to N and L, respectively (Fig. 3a).
Construct EP3(L857-F) was made by mutation of the L857 residue
in S(EP3) to F (Fig. 3a). Western blot analysis of cells expressing
these constructs detected the S1 and S2 species as well as the full-
length forms (Fig. 3b, lanes 6–8). Immunofluorescent staining
showed formation of syncytia in cells expressing CK(S826-N)
(Fig. 3c, panel CK(S826-N), suggesting that mutation of S836 to N
did not affect the cell–cell activity of S(CK). Cell-cell fusion and
syncytia formation were also observed in cells expressing
EP3(L857-F) but not CK(F857-L) (Fig. 3c, panels EP3(L857-F)
and CK(F857-L)), demonstrating that the L857-F mutation
introduced into S(EP3) renders the protein fusogenic in cultured
cells. On the other hand, mutation of the F857 residue to L totally
abolishes the fusion activity of S(CK) (Fig. 3c, panel CK(F867-L).
The relative cell–cell fusion activities of these S constructs are
CK(S826-N).EP3(L857-F)&EP3=CK(F857-L). These results
Figure 1. Summary of amino acid substitutions in the IBV S genes from chicken embryo- and cell culture-adapted IBV Beaudette
strains. a. Schematic diagram of the IBV S gene structure and functional domains. Also shown are amino acid substitutions in the S protein derived
from IBV strains EP3 (accession No. AAY24433), p7 (accession No. AAY21245), p65 (accession No. AAY24433) and CK (accession No. CAC39114). Black
dots indicate the identified amino acid positions that affect the cell–cell fusion activity of S protein in this study. b. Comparison of amino acid
sequences in the heptad repeat I region of S proteins from coronavirus feline infectious peritonitis virus (FIPV), transmissible gastroenteritis virus
(TGEV), porcine epidemic diarrhea virus (PEDV), human coronavirus 229E (HCoV 229E), human coronavirus NL63 (HCoV NL63), SARS-CoV, human
coronavirus HKU1 (HCoV HKU1), bovine coronavirus (BCoV), mouse hepatitis virus (MHV) A59, MHV JHM, IBV strains EP3, p65 and Beau-CK.
doi:10.1371/journal.pone.0006130.g001
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mutation in the heptad repeat 1 region of the protein.
The F857-L substitution was then introduced into the S
constructs cloned from Vero-adapted IBV (p7) and (p65),
respectively, generating S(p7) and S(p65) (Fig. 3a). Expression of
these constructs showed cell–cell fusion and syncytia formation in
cell expressing wild type S(p7) and S(p65), but not the mutant S
proteins (Fig. 3c, panel p7, p7(F857-L), p65 and p65(F857-L)). The
expression levels of both F857-L mutants were lower than the wild
type constructs, but no significant difference in the S1/S2 cleavage
was observed (Fig. 3b, lane 9–12). The relative cell–cell fusion
activities of these S constructs are p65.p7&EP3=p7(F857-
L)=p65(F857-L). These data indicate that S protein acquires its
cell–cell fusion activity by the L857-F mutation during adaptation
to both CK and Vero cells.
Further mutationsof the L857 residue to other amino acids based
on S(EP3) weremade. Asshown inFig. 3a,the L857 wasmutated to
Y, S, E, I and K, respectively. Expression of these mutant constructs
showed that mutations of L857 to Y and S exhibited similar effect
on cell–cell fusion as the L857-F mutant. Cell-cell fusion and
syncytia formation were observed in cells expressing these two
mutants (Fig. 3c). However, much less cell–cell fusion and smaller-
sized syncytia were observed in cells expressing L857-E, L857-K
and L857-I mutant constructs (Fig. 3c). The relative cell–cell fusion
activities of these S constructs are EP3(L857-Y).EP3(L857-
S).EP3(L857-E).EP3(L857-I)=EP3(L857-K).EP3.
Introduction of the F857-L substitution back to the
genome of Vero-adapted IBV and analysis of its effect on
viral infectivity in cultured cells
The F857-L mutation was then introduced back to the genome
of Vero-adapted IBV by using an infectious clone system based on
p65 [16,17] to test its influence on viral recovery and infectivity. In
vitro synthesized full-length transcripts derived from wild type
(rIBV) and mutant (FL) clones were introduced into Vero cells by
electroporation. At 3 days post-electroporation, syncytia formation
Figure 2. Induction of cell–cell fusion by S(EP3) and S(CK) constructs. a. Western blot analysis of cells expressing IBV N (lane 1), S(EP3) (lane
2) and S(CK) (lane 3). Vero cells were infected with vaccinia/T7 recombinant virus and transfected with the indicated constructs. Cells were harvested
at 12 hours post-transfection and lysates prepared. The viral protein expression was analyzed by Western blot with rabbit anti-IBV S and anti-IBV-N
polyclonal antibodies. The same membrane was also probed with anti-b-tubulin monoclonal antibody as a loading control. b. Detection of cell–cell
fusion by indirect immunofluorescence. Vero cells were infected with vaccinia/T7 recombinant virus and transfected with the indicated constructs.A t
12 hours post-transfecion, cells were fixed with 4% paraformaldehyde and stained with rabbit anti-IBV S and anti-IBV N polyclonal antibodies. c. Cell
surface expression of S(EP3) and S(CK) constructs. Vero cells were infected with the vaccinia/T7 recombinant virus and transfected with the indicated
constructs. At 12 hours post-transfecion, cells were either stained directly with 1:100 diluted rabbit anti-IBV S polyclonal antibodies (panels A, B and
C), or permeabilized with 0.1% saporin following by staining with the same antibodies (panels D, E and F). The cells were then incubated with 1:20
diluted FITC-conjugated swine anti-rabbit antibody, fixed with 1% ice cold paraformaldehyde and analyzed by flow cytometry.
doi:10.1371/journal.pone.0006130.g002
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transcripts. No apparent CPE was observed in cells electroporated
with the mutant transcripts at this time point. Upon extension of
the incubation time to 6 days, smaller-sized syncytia appeared.
Therecombinantwildtypeandmutantviruses(p0)wererecovered
from the culture media at 3 and 6 days post-electroporation,
respectively, and further propagated on Vero cells for 5 passages.
Total RNA was extracted from the culture media of cells infected
with each passage of the mutant virus and RT-PCR was carried out
to amplify the S gene. The RT-PCR products were cloned, 10
bacterial clones were randomly chosen from p0, and the complete
nucleotide sequence of the S gene was determined to confirm if the
recovered virus maintains the F857-L substitution. As shown in
table 1, L857 was found in all 10 clones. However, only five clones
had an identical sequence with the original mutant S gene (type FL),
and additional mutations at other positions were found in the other
five clones (Table 1). Among them, two clones contain a T773-S
substitution (FLv1), one contains an I769-V substitution (FLv2), and
twocontain Q523-L and I769-V substitutions(FLv3)(Table 1).These
results demonstrate that the recovered FL mutant virus from p0
contains a mixed population of quasispecies.
To investigate which quasispecies would become dominant in
the subsequent passages, sequencing analysis of bacterial clones
containing the PCR fragments from p1, p3 and p5 was performed.
In the four clones chosen from p1, a homogenous S gene with both
Q523-L and I769-V (FLv3) mutations was found (Table 1).
Subsequent sequencing of clones derived from p3 and p5 each
showed that six out of 10 clones from p3 and two out of 10 clones
from p5 are FLv3 (Table 1). The dominant clones contain an
additional proline to serine substitution at amino acid position 327
(FLv4) (Table 1).
The recovered viruses were then plaque-purified. Compared
to wild type IBV, rIBV showed similar growth kinetics in Vero
cells (Fig. 4b), but formed slighlty smaller plaques (Fig. 4a) with
lower expression level of S protein (Fig. 4c). A total of 20 mutant
viruses was plaque-purified from passages 3 and 5, and the S
gene of all purified viruses was shown to share the same
sequence as FLv4 (Table 1). The FLv4 mutant virus formed
similar-sized plaques as rIBV (Fig. 4a) with slightly lower
expression of S protein (Fig. 4c). Interestingly, the mutant virus
produced up to 10-fold higher titers of virus, compared to rIBV
(Fig. 4b).
Figure 3. Acquisition of the cell–cell fusion activity by L857-F mutation in the heptad repeat 1 region and mutational analysis of the
L857 residue. a. Schematic diagram of variouswild type and mutantS constructs as well as several chimeric constructs used in this study.b. Western blot
analysis of cells expressing wild type, mutants, and chimeric IBV S constructs. Vero cells were infected with vaccinia/T7 recombinant virus and transfected
withtheindicatedconstructs.Cellswereharvestedat12hourspost-transfectionandlysatesprepared.TheviralproteinexpressionwasanalyzedbyW e st e r n
blot with rabbit anti-IBV S antibodies. The same membrane was also probed with anti-b-tubulin monoclonal antibody as a loading control. c. Detection of
cell–cell fusion by indirect immunofluorescence. Vero cells were infected with vaccinia/T7 recombinant virus and transfected with the indicated S
constructs. At 12 hours post-transfecion, cells were fixed with 4% paraformaldehyde and stained with rabbit anti-IBV S polyclonal antibodies.
doi:10.1371/journal.pone.0006130.g003
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protein carrying the F875-L mutation by compensatory
mutations in the S1 region
The cell–cell fusion activity of S proteins cloned from the
mutant IBV construct FL and the four variants (FLv1, FLv2, FLv3
and FLv4) was analyzed by expression in Vero cells. Once again,
expression of these constructs led to the detection of S1 and S2
species as well as the full-length forms (Fig. 5a). Higher levels of S
protein were detected in cells expressing S(FLv3) and S(FLv4),
comparing to cells expressing the other two S constructs (Fig. 5a).
Immunofluorescent staining showed the formation of giant
syncytia in cells expressing S(FLv3) and S(FLv4) (Fig. 5b, panels
Figure 4. Analysis of the effect of L857 residue on IBV infectivity and growth properties by re-introduction of F857-L back into the
genome of Vero-adapted IBV p65. a. Comparison of the plaque sizes of wild type IBV (IBV), wild type recombinant IBV (rIBV) and variant 4 (rFLv4).
Confluent monolayers of Vero cells grown on 6-well plates were infected with wild type IBV (IBV), wild type recombinant IBV (rIBV) and variant 4
(rFLv4), and incubated in the presence of 0.5% carboxymethy cellulose. At 2 days post-infection, cells were washed, fixed with 4% formaldehyde, and
stained with 0.1% toluidine blue. b. Comparison of the growth curves of wild type IBV (IBV), wild type recombinant IBV (rIBV) and variant 4 (rFLv4).
Vero cells were infected with viruses, harvested at 0, 4, 8, 12, 18, 24, 30, 36 and 48 hours post-infection, and TCID50 was determined. c. Analysis of S
protein expression in cells infected with wild type IBV (IBV), wild type recombinant IBV (rIBV) and variant 4 (rFLv4). Vero cells infected with the
indicated viruses with the same MOI were harvested at 16 hours post-infection. The viral protein expression was analyzed by Western blot with rabbit
anti-IBV S antibodies. The same membrane was also probed with anti-b-tubulin monoclonal antibody as a loading control.
doi:10.1371/journal.pone.0006130.g004
Table 1. Summary of amino acid substitutions in S protein from the rescued IBV variants.
Passage S gene type No. of clones (No./total) Amino acid residue
Plaque purification
(No./total)
327 523 769 773 857
p0 FL 5/10 P Q I T L ND
FLv1 2/10 P Q I S L ND
FLv2 1/10 P Q V T L ND
FLv3 2/10 P L V T L ND
p1 FLv3 4/4 P L V T L ND
p3 FLv3 4/10 P L V T L 0/10
FLv4 6/10 S L V T L 10/10
p5 FLv3 2/10 P L V T L 0/10
FLv4 8/10 S L V T L 10/10
doi:10.1371/journal.pone.0006130.t001
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cells expressing S(FLv2) (Fig. 5b, panel S(FLv2)). No obvious cell–cell
fusion was observed in cells expressing S(FL) and S(FLv1) (Fig. 5b,
panels S(FL) and S(FLv1)). The relative cell–cell fusion activities of
these S constructs are FLv4.FLv3.FLv2&EP3=FL=FLv1.
These results confirm that acquisition of the cell–cell fusion activity
is an important step for adaptation of IBV in cultured cells.
Since amino acid difference between S(FLv2) and S(FLv3) was
only at the 523
th residue, the S(FL(Q523-L)) construct was also
created and expressed. The results showed that it displayed a
similar cell–cell fusion activity as FLv2 (=FL(I769-V)) (Fig. 5a lane
3, and Fig. 5b panel FL(Q523-L)). Interestingly, when Q523-L and
I769-V mutations were separately introduced into S(EP3), both
mutants showed a weak cell–cell fusion activity in Vero cells
(Fig. 5b panel EP3, EP3(Q523-L) and EP3(I769-V)). The relative
cell–cell fusion activities of these S constructs are FL(Q523-
L)=FLv2&EP3(Q523-L).EP3(I769-V).EP3. These results re-
veal that Q523-L and I769-V substitutions are sufficient to
compensate the inhibitory effect of F857-L reverse mutation in the
FL construct.
Further enhancement of the cell–cell fusion activity of S
protein and adaptation of IBV to cell culture by G405-D
substitution
Vero-adapted IBV gradually increased its infectivity in Vero cells
by serial passages and a significant difference between p7 and p65
was observed [10]. Comparison of amino acid sequences between
S(p7) and S(p65) revealed a single mutation at the amino acid
position 405 (G405-D) in S(p65) (Fig. 1a). To analyze the possibility
that the enhanced infectivity of p65 virus is due to the enhanced
cell–cell fusion activity of the corresponding S protein, S(p7) and
S(p65) constructs were created and expressed in Vero cells. Efficient
induction of cell–cell fusion was observed in cells transfected with
both constructs (Fig. 6a, panels S(p7) and S(p65) and 6b, lanes 3 and
4). Comparatively, significantly larger syncytia was observed in cells
expressing S(p65) construct than in cells expressing S(p7) (Fig. 6a),
demonstrating that the additional G405-D mutation in S(p65) may
enhance its cell–cell fusion activity. The G405-D mutation was then
introduced into S(EP3) and S(CK) and expressed (Fig. 6a), showing
that introduction of G405-D mutation into S(CK) drastically
enhanced its cell–cell fusion activity (Fig. 6b). Interestingly,
introduction of the mutation into S(EP3) and expression of the
construct in Vero cells showed formation of small syncytial cells
(Fig. 6b). The relative cell–cell fusion activities of these S constructs
are CK(G405-D).p65.CK&p7.EP3(G405-D).EP3.
Discussion
Avian coronaviruses have been isolated from chicken, turkey
and pheasant and may exist in many other avian species [20]. IBV
is usually associated with respiratory disease in domestic fowl, and
was believed to have a limited host range. Chicken is the only
natural host. Similarly, coronaviruses originated from human and
other animal species were considered to have narrow host
specificities until the identification of SARS-CoV as the causative
agent of SARS outbreaks in 2003. The current model of animal
origin of SARS-CoV highlights the importance of cross-species
adaptation and transmission of animal coronaviruses to human.
Cross-species transmission of virus infection has long been
recognized as a way for the emergence of many zoonotic diseases.
The molecular basis for this phenomenon would lie on the rapid
adaptation of certain viruses to a changing environment through
selection of minor variants from quasispecies, accumulation of
mutations, recombination between minor variants, and reassort-
ment of their genomes. A better understanding of the underlying
mechanisms that control these events would be essential for
providing safeguards to limit the impact of these devastating
diseases. In this study, we show that acquisition and enhancement
of the cell–cell fusion activity by amino acid substitutions in the S
protein are critical for interspecies adaptation and infectivity of
IBV to cultured cells. Data present clearly show that the L857-F
Figure 5. Induction of cell–cell fusion by various L857-containing S constructs. a. Western blot analysis of cells expressing L857-containign
S constructs, S(FL), S(FLv1), S(FLv2), S(FLv3) and S(FLv4). Vero cells were infected with vaccinia/T7 recombinant virus and transfected with the
indicated constructs. Cells were harvested at 12 hours post-transfection and lysates prepared. The viral protein expression was analyzed by Western
blot with rabbit anti-IBV S antibodies. The same membrane was also probed with anti-b-tubulin monoclonal antibody as a loading control. b.
Detection of cell–cell fusion by indirect immunofluorescence. Vero cells were infected with vaccinia/T7 recombinant virus and transfected with the
indicated S constructs. At 12 hours post-transfecion, cells were fixed with 4% paraformaldehyde and stained with rabbit anti-IBV S polyclonal
antibodies.
doi:10.1371/journal.pone.0006130.g005
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cell-culture-adapted IBV is important for adaptation of the virus to
cell culture systems, and an additional mutation in the S1 region
(G405-D) could enhance this process. As S protein carrying the
L857-F mutation is able to induce cell–cell fusion, but losses the
activity when F857 was mutated back to L, it suggests that
induction of cell–cell fusion is an essential step in adaptation/
selection of IBV to cultured mammalian cells.
Coronavirus S protein is the major determinant for viral entry
and host specificity. It is a class I fusion protein and mediates viral
entry by specific binding of the S1 domain to a host cell receptor
[21–25]. The cellular receptors for several coronaviruses have
been identified, including members of the cacinoembryonic
antigen family of cell adhesion molecules as the receptor for
MHV, angiotensin converting enzyme II for SARS-CoV and
human coronavirus NL63, and aminopeptidase N for human
coronavirus 229E and TGEV [26–30]. To date, the receptor(s) for
IBV has not been identified in its native or adapted host cells. It is
assumed that a mammalian counterpart on Vero cells could be
used as a receptor for IBV at low affinity, and might have
structural and functional similarities to the native receptor on
chicken cells. At the initial stages of the adaptation process, a
certain proportion of EP3 would weakly bind to this molecule and
gains entry into the cells by endocytosis. In addition, binding of
IBV to sialic acid was reported to be important for adaptation of
the virus to human cells [31,32]. The Beaudette strain of IBV was
also reported to have an additional binding activity to heparin-like
structures [33]. These additional binding activities may help to
Figure 6. Further enhancement of the cell–cell fusion activity by G405-D mutation in the S1 region. a. Western blot analysis of cells
expressing S(EP3), S(CK), S(p7), S(p65), S(EP3(G405D)) and S(CK(G405D)) constructs. Vero cells were infected with vaccinia/T7 recombinant virus and
transfected with the indicated constructs. Cells were harvested at 12 hours post-transfection and lysates prepared. The viral protein expression was
analyzed by Western blot with rabbit anti-IBV S antibodies. The same membrane was also probed with anti-b-tubulin monoclonal antibody as a
loading control. b. Detection of cell–cell fusion by indirect immunofluorescence. Vero cells were infected with vaccinia/T7 recombinant virus and
transfected with the indicated S constructs. At 12 hours post-transfecion, cells were fixed with 4% paraformaldehyde and stained with rabbit anti-IBV
S polyclonal antibodies.
doi:10.1371/journal.pone.0006130.g006
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receptor by mutation.
To uncoat the engulfed virion and to establish subsequent
infection cycles as well as to spread infection to neighboring cells,
acquisition of virus-cell/cell–cell membrane fusion and enhance-
ment of the cell–cell fusion activity would be an essential step for
successful selection/adaptation of virus to the new host cells.
Membrane fusion mediated by coronavirus, similar to other viruses,
is a multistep process. It includes binding of the S protein to one or
more receptors, conformational changes of the protein to a fusion-
active form and the actual fusion process. The membrane-fusion
activity of coronavirus S protein is mainly associated with domains
in the S2 region of the protein [34–38]. In this study, we
demonstrate that L857-F substitution in the S2 region of the IBV
S protein confers the S protein from non-fusogenic to fusogenic.
This mutation may affect one of these fusion steps and thus modify
the fusion activity of S protein and syncytia formation. At the same
time, the virus was successfully adapted to the cultured cells with
enhanced infectivity, confirming that acquisition of membrane
fusion is an important step in selection/adaptation of IBV to cell
culture and may also play a crucial role in cross-species adaptation
and transmission of IBV in cultured cells.
Further enhancement of the cell–cell fusion activity of IBV S
protein was achieved by a single amino acid substitution (G405-D)
in p65 virus. This mutation, meanwhile, enhances the infectivity of
the virus in cultured cells. The enhancement effect by mutations in
the S1 region and its significance on viral infectivity was further
demonstrated by cloning and expression of S gene derived from
the IBV variants rescued from the full-length transcripts
containing the F857-L mutation. In variants FLv3 and FLv4,
additional amino acid substitutions (Q523-L and I769-V) greatly
enhanced the cell–cell fusion activity of the L857-containig S
protein and the infectivity of the recovered virus. The involvement
of residues in the S1 region in the cell–cell fusion activity of S
protein was also demonstrated in other coronaviruses [25]. These
results illustrate the complexity of the fusion process and the
involvement of multiple domains in the induction of membrane
fusion. It is worth mentioning that the cell–cell fusion activity of
various S constructs was approximated by the degree of cell–cell
fusion induced in cells overexpressing individual constructs. In a
previous report, we showed nice correlation between the cell–cell
fusion activity of two S constructs and their expression levels in the
cells [39]. This correlation was also observed in this study with
more wild type and mutant S constructs.
Based on data generated from adaptation [10] and cell–cell
fusion studies presented here, a model of two-step adaptation
process is proposed (Fig. 7). In this model, the adaptation was
divided into primary and secondary adaptation (Fig. 7). Early
passages of Vero-adapted IBV, including p7, p12, p14 and p20,
belong to the primarily adapted group (Fig. 7). Other cell culture-
adapted strains, including the CK-adapted and Beaudette-US
strains CAC39114 and CAC39300 [8,9], and the Vero-adapted
strain AAV98206 described by Youn et al. [13], also belong to this
group (Fig. 7). Late passages of Vero-adapted IBV, including p36,
p50 and p65, contain the additional G405-D amino acid
substitution and belong to the secondarily adapted group (Fig. 7).
Except in the cell culture-adapted IBV strains, the L857 residue
was found to be absolutely conserved in all coronaviruses
sequenced so far. As structural information for this IBV S protein
is currently lacking [40,41], we are unclear the overall role of this
residue on the formation and stability of the six-bundle structure of
the protein. Further structural and functional studies are required
to delineate the precise roles of this mutation in the fusion process.
Mutation of this residue to either a Ser or a Tyr showed similar
effect on the cell–cell fusion activity of the S protein as a Phe. On
the other hand, when the residue was mutated to Ile, Glu or Lys, a
much lower cell–cell fusion activity of the S protein was observed.
Interestingly, mutations in the S1 and some distant S2 regions
could compensate the effect of F857-L mutation. This may explain
why S protein from several other coronaviruses, such as MHV and
human coronavirus, could induce efficient virus-cell/cell–cell
fusion although a conserved Leu residue was found at the
equivalent position [42,43].
It is worth mentioning that the cell–cell fusion activities of
different S constructs were qualitatively and semi-quantitatively
determined in cells overexpressing individual S constructs using
the vaccinia/T7 expression system. Attempts to obtain more
rigorous quantitative data were unsuccessful. As shown in this
Figure 7. Diagram showing a two-step adaptation process of chicken embryo-adapted IBV to Vero cells. Also shown are the numbers
of amino acid changes during each adaptation process.
aThe accession No. for S genes from EP3 is DQ001338, p7 is DQ001337, p65 is DQ001339.
bThe accession No. for this Vero-adapted strain is AAV98206.
cThe accession No. for these two strains are CAC39114 and CAC39300.
doi:10.1371/journal.pone.0006130.g007
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probably due to the presence of an ER retention signal [44]. Since
cell surface expression of S protein is a prerequisite for the
induction of cell–cell fusion, disruption of the ER-retention signal
may facilitate cell surface expression as well as quantitative analysis
of the cell–cell fusion activity of the protein.
As virus-cell/cell–cell fusion is essential for efficient propagation
of viral infection, attempts to interfere this process with fusion
inhibitors, such as peptides or small molecules, are being made for
several viruses, including HIV, SARS-CoV and influenza virus.
The involvement of multiple domains in the induction of cell–cell
fusion demonstrated here would complicate the design of such
inhibitors. Furthermore, mutations in regions beyond the target
sequence, in the case of coronaviruses the S1 and some distant S2
regions, may lead to the emergence of drug-resistant strains.
Understanding of the fusion mechanisms in more detail would,
therefore, help design more efficient inhibitors.
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